title: Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
authors.forename: E
authors.initials: E
authors.lastname: Perucca
authors.forename: E
authors.initials: E
authors.lastname: Marchioni
authors.forename: D
authors.initials: D
authors.lastname: Soragna
authors.forename: F
authors.initials: F
authors.lastname: Savoldi
mesh_terms: D000368:Aged; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism*; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology*; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D019389:Cytochrome P-450 CYP2D6; D005473:Fluoxetine; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors